{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:25:02Z","timestamp":1792081502537,"version":"4.4.0"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"crossref","award":["N01MH90003"],"award-info":[{"award-number":["N01MH90003"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.pnpbp.2013.05.011","type":"journal-article","created":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T16:15:27Z","timestamp":1370103327000},"page":"183-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":174,"special_numbering":"C","title":["Pharmacogenetics in major depression: A comprehensive meta-analysis"],"prefix":"10.1016","volume":"45","author":[{"given":"Tomihisa","family":"Niitsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Serretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2013.05.011_bb0005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jad.2010.02.115","article-title":"BDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression","volume":"125","author":"Alexopoulos","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0740","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/0269881105049037","article-title":"Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram","volume":"19","author":"Arias","year":"2005","journal-title":"J. Psychopharmacol. (Oxf.,)"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jad.2005.11.008","article-title":"Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin","volume":"90","author":"Arias","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000317285","article-title":"Norepinephrine and serotonin transporter genes: impact on treatment response in depression","volume":"62","author":"Baffa","year":"2010","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0025","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.mp.4002142","article-title":"Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions","volume":"13","author":"Bakker","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0030","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/mp.2008.16","article-title":"Meta-analysis of two genome-wide association studies of bipolar disorder reveals important points of agreement","volume":"13","author":"Baum","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0035","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/sj.npp.1301462","article-title":"Association of the COMT val158met variant with antidepressant treatment response in major depression","volume":"33","author":"Baune","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2008.03.001","article-title":"Serotonin receptor 1A-1019C\/G variant: impact on antidepressant pharmacoresponse in melancholic depression?","volume":"436","author":"Baune","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0045","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-008-1381-7","article-title":"The catechol-O-methyltransferase Val(108\/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting","volume":"203","author":"Benedetti","year":"2009","journal-title":"Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0050","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.eurpsy.2009.12.007","article-title":"Effect of catechol-O-methyltransferase Val(108\/158)Met polymorphism on antidepressant efficacy of fluvoxamine","volume":"25","author":"Benedetti","year":"2010","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng1934","article-title":"Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database","volume":"39","author":"Bertram","year":"2007","journal-title":"Nat. Genet."},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2013.05.011_bb0060","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1016\/j.psyneuen.2009.05.021","article-title":"The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders","volume":"34","author":"Binder","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0065","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng1479","article-title":"Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment","volume":"36","author":"Binder","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0070","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3109\/15622975.2012.665477","article-title":"Stress-related depression: neuroendocrine, genetic, and therapeutical aspects","volume":"13","author":"Bosch","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0075","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/15622970701308397","article-title":"Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder","volume":"9","author":"Bozina","year":"2008","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0080","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1176\/appi.ajp.2009.09040576","article-title":"Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study","volume":"167","author":"Brent","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0090","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jad.2009.02.023","article-title":"Interaction between genetic polymorphisms and stressful life events in first episode depression","volume":"119","author":"Bukh","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0085","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.euroneuro.2009.11.004","article-title":"No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment","volume":"20","author":"Bukh","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0095","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3109\/07420521003681480","article-title":"T3111C clock single nucleotide polymorphism and mood disorders: a meta-analysis","volume":"27","author":"Calati","year":"2010","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0100","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jad.2010.07.006","article-title":"Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder","volume":"126","author":"Chi","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000087847","article-title":"Serotonin receptor 2A gene polymorphism (\u22121438A\/G) and short-term treatment response to citalopram","volume":"52","author":"Choi","year":"2005","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0110","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2006.08.012","article-title":"Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder","volume":"1118","author":"Choi","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0115","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.86.2.695","article-title":"Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood\u2013brain barrier sites","volume":"86","author":"Cordon-Cardo","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0745","first-page":"27","article-title":"Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity","volume":"5","author":"Cusin","year":"2002","journal-title":"Int. J. neuropsychopharmacol.\/Off.Sci. J. Coll. Int. Neuropsychopharmacol. (CINP)."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/gte.2007.0089","article-title":"Serotonin transporter gene polymorphisms and sertraline response in major depression patients","volume":"12","author":"Dogan","year":"2008","journal-title":"Genet. Test."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0750","first-page":"93","article-title":"Brain-derived neurotrophic factor (BDNF) gene: no major impact on antidepressant treatment response","volume":"13","author":"Domschke","year":"2010","journal-title":"Int. J. Neuropsychopharmacol.\/Off. Sci. J. Coll. Int. Neuropsychopharmacol.(CINP)."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0135","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","article-title":"The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function","volume":"112","author":"Egan","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0140","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0145","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0022-3956(98)00004-1","article-title":"Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees","volume":"32","author":"Franchini","year":"1998","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0150","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/FTD.0b013e31817d6f5d","article-title":"CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response","volume":"30","author":"Gex-Fabry","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0155","doi-asserted-by":"crossref","first-page":"13208","DOI":"10.1073\/pnas.0605180103","article-title":"Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects","volume":"103","author":"Govindarajan","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0160","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jad.2010.06.002","article-title":"The role of clinical variables, neuropsychological performance and SLC6A4 and COMT gene polymorphisms on the prediction of early response to fluoxetine in major depressive disorder","volume":"127","author":"Gudayol-Ferre","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0170","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00041444-200512000-00014","article-title":"No association between the tryptophan hydroxylase gene polymorphism and major depressive disorders and antidepressant response in a Korean population","volume":"15","author":"Ham","year":"2005","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0165","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pnpbp.2006.08.001","article-title":"Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population","volume":"31","author":"Ham","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0175","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1440-1819.2010.02113.x","article-title":"Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions","volume":"64","author":"Hashimoto","year":"2010","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0180","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.tpj.6500340","article-title":"Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder","volume":"6","author":"Hong","year":"2006","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0190","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/npp.2009.180","article-title":"Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment","volume":"35","author":"Horstmann","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0195","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.biopsych.2004.01.029","article-title":"Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression","volume":"55","author":"Hranilovic","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0200","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1192\/bjp.bp.108.062521","article-title":"Moderation of antidepressant response by the serotonin transporter gene","volume":"195","author":"Huezo-Diaz","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00406-006-0679-x","article-title":"Brain-derived neurotrophic factor (BDNF) polymorphisms G196A and C270T are not associated with response to electroconvulsive therapy in major depressive disorder","volume":"257","author":"Huuhka","year":"2007","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0215","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/WNR.0b013e32832eb708","article-title":"5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression","volume":"20","author":"Illi","year":"2009","journal-title":"Neuroreport"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.psychres.2009.03.010","article-title":"Catechol-O-methyltransferase val108\/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder","volume":"176","author":"Illi","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0220","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0165-1781(02)00141-5","article-title":"A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine","volume":"111","author":"Ito","year":"2002","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0225","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/tpj.2010.69","article-title":"Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response","volume":"12","author":"Ji","year":"2012","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0755","first-page":"339","article-title":"Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline","volume":"6","author":"Joyce","year":"2003","journal-title":"Int. J. Neuropsychopharmacol.\/Off.Sci.J. Coll. Int.Neuropsychopharmacol. (CINP)."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0240","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2190\/PM.37.3.h","article-title":"Effect of serotonin receptor 2A gene polymorphism on mirtazapine response in major depression","volume":"37","author":"Kang","year":"2007","journal-title":"Int. J. Psychiatry Med."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000109970","article-title":"Relationship between G-protein beta-3 subunit C825T polymorphism and mirtazapine responses in Korean patients with major depression","volume":"56","author":"Kang","year":"2007","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0760","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1177\/0269881109105457","article-title":"Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression","volume":"24","author":"Kang","year":"2010","journal-title":"J.psychopharmacol.(Oxf.)"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0265","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/mp.2008.116","article-title":"Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder","volume":"15","author":"Kato","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0255","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000094727","article-title":"Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients","volume":"53","author":"Kato","year":"2006","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0270","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000119734","article-title":"No association of TPH1 218A\/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression","volume":"56","author":"Kato","year":"2007","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0250","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.pnpbp.2007.09.003","article-title":"ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder","volume":"32","author":"Kato","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0275","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.pnpbp.2008.01.019","article-title":"Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients","volume":"32","author":"Kato","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0260","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ajmg.b.30783","article-title":"Effect of 5-HT1A gene polymorphisms on antidepressant response in major depressive disorder","volume":"150B","author":"Kato","year":"2009","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0765","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1177\/0269881110376683","article-title":"Variation in GNB3 predicts response and adverse reactions to antidepressants","volume":"25","author":"Keers","year":"2011","journal-title":"J.psychopharmacol. (Oxf.,)"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0285","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00001756-200001170-00042","article-title":"Serotonin transporter gene polymorphism and antidepressant response","volume":"11","author":"Kim","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0290","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/jama.296.13.1609","article-title":"Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression","volume":"296","author":"Kim","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0300","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/sj.mp.4001494","article-title":"Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response","volume":"9","author":"Kirchheiner","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0295","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2217\/14622416.9.7.841","article-title":"Genetic variants in FKBP5 affecting response to antidepressant drug treatment","volume":"9","author":"Kirchheiner","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0305","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hup.1142","article-title":"Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population","volume":"25","author":"Kishi","year":"2010","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0310","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12017-009-8105-y","article-title":"HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort","volume":"12","author":"Kishi","year":"2010","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0320","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/YIC.0b013e328338b884","article-title":"The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case\u2013control association study","volume":"25","author":"Kocabas","year":"2010","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YIC.0b013e32833d18f8","article-title":"Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder","volume":"26","author":"Kocabas","year":"2011","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0325","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/sj.mp.4000334","article-title":"Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder","volume":"2","author":"Kunugi","year":"1997","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0330","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1373\/clinchem.2006.066605","article-title":"ABCB1 (P-glycoprotein\/MDR1) gene G2677T\/a sequence variation (polymorphism): lack of association with side effects and therapeutic response in depressed inpatients treated with amitriptyline","volume":"52","author":"Laika","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0335","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/sj.tpj.6500217","article-title":"Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders","volume":"4","author":"Lee","year":"2004","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0340","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1440-1819.2005.01348.x","article-title":"Association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder","volume":"59","author":"Lee","year":"2005","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0345","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.biopsych.2007.10.026","article-title":"The FKBP5-gene in depression and treatment response\u2014an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort","volume":"63","author":"Lekman","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0770","first-page":"501","article-title":"Association of the C(\u22121019)G 5-HT1A functional promoter polymorphism with antidepressant response","volume":"7","author":"Lemonde","year":"2004","journal-title":"Int. J. neuropsychopharmacol.\/Off. Sci.J.Coll. Int. Neuropsychopharmacol. (CINP)"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0355","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.mp.4001890","article-title":"Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behavior","volume":"12","author":"Li","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0365","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.schres.2004.03.018","article-title":"Meta-analyses of the association between genetic polymorphisms of neurotrophic factors and schizophrenia","volume":"71","author":"Lin","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0360","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.pnpbp.2009.06.015","article-title":"Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder","volume":"33","author":"Lin","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0370","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/sj.mp.4002088","article-title":"Meta-analyses of genetic studies on major depressive disorder","volume":"13","author":"Lopez-Leon","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0375","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.euroneuro.2009.08.006","article-title":"HTR2A gene variation is involved in antidepressant treatment response","volume":"20","author":"Lucae","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0380","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1185\/030079906X132415","article-title":"Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials","volume":"22","author":"Machado","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2013.05.011_bb0385","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00406-007-1004-z","article-title":"Contribution of allelic variations to the phenotype of response to antidepressants and antipsychotics","volume":"258","author":"Maier","year":"2008","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0775","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1177\/0269881109353463","article-title":"Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance","volume":"24","author":"Mandelli","year":"2010","journal-title":"J.psychopharmacol. (Oxf.,)"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0395","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/503820","article-title":"Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment","volume":"78","author":"McMahon","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0400","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000319361","article-title":"Antidepressants and ABCB1 gene C3435T functional polymorphism: a naturalistic study","volume":"62","author":"Menu","year":"2010","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0405","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.pnpbp.2008.03.018","article-title":"MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression","volume":"32","author":"Mihaljevic Peles","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0410","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00213-009-1550-3","article-title":"Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response","volume":"205","author":"Min","year":"2009","journal-title":"Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0415","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0304-3940(01)01704-9","article-title":"Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression","volume":"303","author":"Minov","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0420","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ajmg.b.30816","article-title":"SLC6A4 variation and citalopram response","volume":"150B","author":"Mrazek","year":"2009","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0425","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2174\/157015911798376262","article-title":"Neurotrophins role in depression neurobiology: a review of basic and clinical evidence","volume":"9","author":"Neto","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0430","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.phrs.2008.09.010","article-title":"Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study","volume":"58","author":"Nikisch","year":"2008","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0435","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/YIC.0b013e328338bcf4","article-title":"5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder","volume":"25","author":"Noro","year":"2010","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0440","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1476-5381.2011.01557.x","article-title":"Interactions between antidepressants and P-glycoprotein at the blood\u2013brain barrier: clinical significance of in vitro and in vivo findings","volume":"165","author":"O'Brien","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0445","doi-asserted-by":"crossref","first-page":"e24840","DOI":"10.1371\/journal.pone.0024840","article-title":"A new anti-depressive strategy for the elderly: ablation of FKBP5\/FKBP51","volume":"6","author":"O'Leary","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0450","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jad.2007.02.017","article-title":"Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment","volume":"104","author":"Papiol","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0455","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/sj.npp.1300992","article-title":"Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study","volume":"31","author":"Parsey","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0460","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.biopsych.2004.06.020","article-title":"The \u22121438A\/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity","volume":"56","author":"Parsons","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0465","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.biopsych.2008.10.002","article-title":"Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder","volume":"65","author":"Perlis","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0475","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.mp.4001502","article-title":"Investigation of serotonin-related genes in antidepressant response","volume":"9","author":"Peters","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FPC.0b013e3283163ecd","article-title":"Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response","volume":"19","author":"Peters","year":"2009","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0480","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1503\/jpn.100059","article-title":"Pharmacogenetics of antidepressant response","volume":"36","author":"Porcelli","year":"2011","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0485","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.euroneuro.2011.10.003","article-title":"Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy","volume":"22","author":"Porcelli","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0490","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/sj.tpj.6500099","article-title":"A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression","volume":"2","author":"Roberts","year":"2002","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0495","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ajmg.b.31019","article-title":"FKBP5 polymorphisms and antidepressant response in geriatric depression","volume":"153B","author":"Sarginson","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0500","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000066394","article-title":"Association between \u22121438G\/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder","volume":"46","author":"Sato","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0520","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1600-0447.1998.tb10117.x","article-title":"Mode of inheritance in mood disorder families according to fluvoxamine response","volume":"98","author":"Serretti","year":"1998","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0530","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0924-977X(01)00113-4","article-title":"Tryptophan hydroxylase gene associated with paroxetine antidepressant activity","volume":"11","author":"Serretti","year":"2001","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0535","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.mp.4000876","article-title":"Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity","volume":"6","author":"Serretti","year":"2001","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0525","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0924-977X(02)00154-2","article-title":"SSRIs antidepressant activity is influenced by G beta 3 variants","volume":"13","author":"Serretti","year":"2003","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0515","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ajmg.b.30027","article-title":"Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders","volume":"129B","author":"Serretti","year":"2004","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0780","first-page":"453","article-title":"The C(\u22121019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings","volume":"7","author":"Serretti","year":"2004","journal-title":"Int. J. neuropsychopharmacol.\/Off.Sci. J. Coll. Int.Neuropsychopharmacol. (CINP)"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YIC.0b013e32831db2d7","article-title":"Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders","volume":"24","author":"Serretti","year":"2009","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0540","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1038\/tp.2012.115","article-title":"ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression","volume":"2","author":"Singh","year":"2012","journal-title":"Transl. psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0545","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.biopsych.2012.09.028","article-title":"Multiple regulatory variants modulate expression of 5-hydroxytryptamine 2A receptors in human cortex","volume":"73","author":"Smith","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0550","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jad.2010.06.021","article-title":"An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: a pilot study","volume":"128","author":"Spronk","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0555","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1017\/S1092852900013997","article-title":"Brain-derived neurotrophic factor: the neurotrophin hypothesis of psychopathology","volume":"13","author":"Stein","year":"2008","journal-title":"CNS Spectr."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0560","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.brainres.2011.08.005","article-title":"The brain-derived neurotrophic factor is associated with alcohol dependence-related depression and antidepressant response","volume":"1415","author":"Su","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0565","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/sj.tpj.6500289","article-title":"The catechol-O-methyltransferase Val108\/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression","volume":"5","author":"Szegedi","year":"2005","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2009.06.036","article-title":"Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder","volume":"1286","author":"Tatro","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0575","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/tpj.2010.12","article-title":"BDNF Val66Met genotype and 6-month remission rates in late-life depression","volume":"11","author":"Taylor","year":"2011","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0785","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature08185","article-title":"Common polygenic variation contributes to risk of schizophrenia and bipolar disorder","volume":"460","author":"The International Schizophrenia C","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0585","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.biopsych.2011.07.023","article-title":"FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior","volume":"70","author":"Touma","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0590","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0595","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ajmg.b.20026","article-title":"Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response","volume":"123B","author":"Tsai","year":"2003","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0605","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/ajmg.b.30246","article-title":"Lack of supporting evidence for a genetic association of the FKBP5 polymorphism and response to antidepressant treatment","volume":"144B","author":"Tsai","year":"2007","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0600","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jad.2008.04.017","article-title":"Sexually dimorphic effect of catechol-O-methyltransferase val158met polymorphism on clinical response to fluoxetine in major depressive patients","volume":"113","author":"Tsai","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0610","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/tpj.2009.12","article-title":"Genetic predictors of response to antidepressants in the GENDEP project","volume":"9","author":"Uher","year":"2009","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0615","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neulet.2011.06.031","article-title":"Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDD","volume":"501","author":"Viikki","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0620","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/YPG.0b013e32832a506e","article-title":"SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A","volume":"19","author":"Villafuerte","year":"2009","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0625","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00213-010-2034-1","article-title":"TPH1 is associated with major depressive disorder but not with SSRI\/SNRI response in Taiwanese patients","volume":"213","author":"Wang","year":"2011","journal-title":"Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0630","unstructured":"Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000. Accessed on Dec 31 2012. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0790","series-title":"WHO paper written for the World Federation of Mental Health","article-title":"DEPRESSION: A Global Public Health Concern","author":"WHO","year":"2012"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0640","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/FPC.0b013e32801a3be6","article-title":"A splice site polymorphism in the G-protein beta subunit influences antidepressant efficacy in depression","volume":"17","author":"Wilkie","year":"2007","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0645","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.tpj.6500491","article-title":"Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy","volume":"9","author":"Wilkie","year":"2009","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0650","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000054938","article-title":"Association study of the 5-HT(6) receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders","volume":"44","author":"Wu","year":"2001","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0660","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jad.2011.04.011","article-title":"Influence and interaction of genetic polymorphisms in catecholamine neurotransmitter systems and early life stress on antidepressant drug response","volume":"133","author":"Xu","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0655","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/YPG.0b013e32834c0c87","article-title":"Brain-derived neurotrophic factor gene polymorphism (Val66Met) and the early response to antidepressant in Chinese Han population","volume":"22","author":"Xu","year":"2012","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0795","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/0269881111414452","article-title":"Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response","volume":"26","author":"Xu","year":"2012","journal-title":"J. psychopharmacol.(Oxf.,)"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0680","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0278-5846(02)00267-1","article-title":"Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder","volume":"26","author":"Yoshida","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0685","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1176\/appi.ajp.161.9.1575","article-title":"Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms","volume":"161","author":"Yoshida","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0800","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/0269881106072192","article-title":"The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine","volume":"21","author":"Yoshida","year":"2007","journal-title":"J. psychopharmacol. (Oxf.,)"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0675","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hup.907","article-title":"Influence of the tyrosine hydroxylase val81met polymorphism and catechol-O-methyltransferase val158met polymorphism on the antidepressant effect of milnacipran","volume":"23","author":"Yoshida","year":"2008","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0690","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.pnpbp.2011.02.009","article-title":"The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients","volume":"35","author":"Yoshimura","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0700","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.euroneuro.2005.12.004","article-title":"Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders","volume":"16","author":"Yu","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0695","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1186\/1471-2105-9-528","article-title":"Gene Prospector: an evidence gateway for evaluating potential susceptibility genes and interacting risk factors for human diseases","volume":"9","author":"Yu","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0705","first-page":"314","article-title":"Association between the 5-HT1A receptor gene polymorphism (rs6295) and antidepressants: a meta-analysis","volume":"27","author":"Zhao","year":"2012","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0710","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/YPG.0b013e32834dc44c","article-title":"Sertraline (Zoloft) response in major depressive disorder is not associated with three 5-HT1A receptor gene polymorphisms (rs6295, rs10042486, or rs1364043) in Chinese-Han patients","volume":"22","author":"Zhao","year":"2012","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0715","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1097\/00001756-200006260-00018","article-title":"Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment","volume":"11","author":"Zill","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0805","first-page":"649","article-title":"DNA sequence variants of the FKBP5 gene are associated with unipolar depression","volume":"13","author":"Zobel","year":"2010","journal-title":"Int. J. Neuropsychopharmacol.\/Off. Sci. J. Coll. Int. Neuropsychopharmacol. (CINP)."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0725","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hup.1099","article-title":"Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine","volume":"25","author":"Zou","year":"2010","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0730","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000265132","article-title":"Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients","volume":"61","author":"Zou","year":"2010","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2013.05.011_bb0735","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.euroneuro.2009.12.005","article-title":"Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder","volume":"20","author":"Zou","year":"2010","journal-title":"Eur. Neuropsychopharmacol."}],"updated-by":[{"DOI":"10.1016\/j.pnpbp.2013.08.006","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T00:00:00Z","timestamp":1385942400000}}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584613001061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584613001061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:42:53Z","timestamp":1759520573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584613001061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":147,"alternative-id":["S0278584613001061"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2013.05.011","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacogenetics in major depression: A comprehensive meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2013.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}